ST NOTEC (688076.SH) subsidiary plans to acquire 100% of Sailicheng's shares for 38.65 million yuan

Zhitong Finance App News, ST Nortech (688076.SH) announced that the company's wholly-owned subsidiary Hangzhou Aosainuo Biotechnology Co., Ltd. (“Auseno”) plans to acquire 100% of the shares of Anji Xingte Enterprise Management Partnership (Limited Partnership) (“AnjiStar”), Hangzhou Jianyi Pharmaceutical Technology Co., Ltd. (“Hangzhou Jianyi”), Pan Yuyou, Pan Yuming, and Wang Wensong in total, with a total transaction price of 38.65 million yuan. After the transaction is completed, Sailicheng will become the company's wholly-owned subsidiary and included in the scope of the company's consolidated statements.

Auseno, a wholly-owned subsidiary of the company, is located at No. 18 Fenghe Road, Xiaya Town, Jiande City, Hangzhou City, Zhejiang Province. It is a biomedical enterprise focusing on customized R&D and production of small molecules. As demand in the downstream market grows, production capacity and site resources have become key factors limiting Sino Australia's order delivery and business expansion. Sailicheng's existing assets and resources invested in API projects have a high strategic synergy advantage for future production capacity upgrades, and Sailicheng's geographical location is close to Auseno. The acquisition will help Auseno integrate surrounding industrial resources, increase Auseno's production capacity for advanced pharmaceutical intermediates and APIs, and is in line with the company's main business development direction.